Angeletti, S., Lorino, G., Gherardi, G. etal. (2001) Routine molecular identification of enterococci by gene-specific PCR and 16S ribosomal DNA sequencing. J Clin Microbiol 39, 794-797. Arduino, R. C., Jacques-Palaz, K., Murray, B. E. and Rakita, R. M. (1994) Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect Immun 62, 5587-5594. Arthur, M. and Courvalin, P. (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37, 1563-1571. Arthur, M. and Quintiliani, R. Jr (2001) Regulation of VanA- and VanB-type glycopeptide resistance in enterococci. Antimicrob Agents Chemother 45, 375-381.

Arthur, M., Molinas, C. and Courvalin, P. (1992) The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 174, 2582-2591. Arthur, M., Molinas, C., Depardieu, F. and Courvalin, P. etal. (1993) Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 175, 117-127. Bonten, M. J., Slaughter, S., Ambergen, A. W. etal. (1998) The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 158, 1127-1132. Bouza, E., San Juan, R., Munoz, P. etal. (2001) A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7, 523-531. Boyce, J. M., Opal, S. M., Chow, J. W. etal. (1994) Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32, 1148-1153. Bozdogan, B. and Leclercq, R. (1999) Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob Agents Chemother 43, 2720-2725. CDC (1995) Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 44, 1-13. CDC (2002a) Staphylococcus aureus resistant to vancomycin - United States,

2002. MMWR Morb Mortal Wkly Rep 51, 565-567. CDC (2002b) Vancomycin-resistant Staphylococcus aureus - Pennsylvania,

2002. MMWR Morb Mortal Wkly Rep 51, 902. Cheng, S., McCleskey, F. K., Gress, M. J. etal. (1997) A PCR assay for identification of Enterococcus faecium. J Clin Microbiol 35, 1248-1250. Chien, J. W., Kucia, M. L. and Salata, R. A. (2000) Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis 30, 146-151. Chow, J. W. (2000) Aminoglycoside resistance in enterococci. Clin Infect Dis 31, 586-589.

Clewell, D. B. and Weaver, K. E. (1989) Sex pheromones and plasmid transfer in Enterococcus faecalis. Plasmid 21, 175-184. Costa, Y., Galimand, M., Leclercq, R. etal. (1993) Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 37, 1896-1903. Coudron, P. E., Markowitz, S. M. and Wong, E. S. (1992) Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 36, 1125-1126. d'Azevedo, P. A., Dias, C. A., Goncalves, A. L. etal. (2001) Evaluation of an automated system for the identification and antimicrobial susceptibility testing of enterococci. Diagn Microbiol Infect Dis 40, 157-161. Das, I. and Gray, J. (1998) Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital. Pediatr Infect Dis J 17, 1154-1158.

Devriese, L. A., Vancanneyt, M., Descheemaeker, P. etal. (2002) Differentiation and identification of Enterococcus durans, E. hirae and E. villorum. J Appl Microbiol 92, 821-827.

Donskey, C. J., Chowdhry, T. K., Hecker, M. T. etal. (2000) Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343, 1925-1932.

Duh, R. W., Singh, K. V., Malathum, K. and Murray, B. E. (2001) In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Microb Drug Resist 7, 39-46.

Durand, M. L., Calderwood, S. B., Weber, D. J. etal. (1993) Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328, 21-28.

Dutka-Malen, S., Blaimont, B., Wauters, G. and Courvalin, P. (1994) Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother 38, 1675-1677.

Dutka-Malen, S., Molinas, C., Arthur, M. and Courvalin, P. (1992) Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 112, 53-58.

Edmond, M. B., Wallace, S. E., McClish, D. K. etal. (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29, 239-244.

Eliopoulos, G. M. (1993) Aminoglycoside resistant enterococcal endocarditis. Infect Dis Clin North Am 7, 117-133.

Ennahar, S., Cai, Y. and Fujita, Y. (2003) Phylogenetic diversity of lactic acid bacteria associated with paddy rice silage as determined by 16S ribosomal DNA analysis. Appl Environ Microbiol 69, 444-451.

Evers, S. and Courvalin, P. (1996) Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR(B) two-component regulatory system in Enterococcus faecalis V583. J Bacteriol 178, 1302-1309.

Facklam, R. R. and Collins, M. D. (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27, 731-734.

Facklam, R. R., Padula, J. F., Thacker, L. G. et al. (1974) Presumptive identification of group A, B, and D streptococci. Appl Microbiol 27, 107-113.

Facklam, R., Hollis, D. and Collins, M. D. (1989) Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria. J Clin Microbiol 27, 724-730.

Facklam, R. R., Carvalho, M. G. and Teixeira, L. M. (2002) History, taxonomy, biochemical characteristics, and antibiotic susceptibility testing of enterococci. In The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance. M. S. Gilmore, D. B. Clewell, P. M. Courvalin etal. Washington, DC: ASM Press: 1-54.

Ferretti, J. J., Gilmore, K. S. and Courvalin, P. (1986) Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 167, 631-638.

Fontana, R., Cerini, R., Longoni, P. etal. (1983) Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin. J Bacteriol 155, 1343-1350.

Fontana, R., Ligozzi, M., Pittaluga, F. and Satta, G. (1996) Intrinsic penicillin resistance in enterococci. Microb Drug Resist 2, 209-213.

Fraimow, H. S., Jungkind, D. L., Lander, D. W. etal. (1994) Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med 121, 22-26.

Garcia-Garrote, F., Cercenado, E. and Bouza, E. (2000) Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol 38, 2108-2111.

Gonzales, R. D., Schreckenberger, P. C., Graham, M. B. etal. (2001) Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179.

Gorbach, S. L. (1993) Treatment of intra-abdominal infections. J Antimicrob Chemother 31 (Suppl. A), 67-78.

Gould, K., Ramirez-Ronda, C. H., Holmes, R. K. and Sanford, J. P. (1975) Adherence of bacteria to heart valves in vitro. J Clin Invest 56, 1364-1370.

Gutschik, E., Moller, S. and Christensen, N. (1979) Experimental endocarditis in rabbits. 3. Significance of the proteolytic capacity of the infecting strains of Streptococcus faecalis. Acta Pathol Microbiol Scand [B] 87, 353-362.

Hamilton-Miller, J. M. and Shah, S. (1999) Identification of clinically isolated vancomycin-resistant enterococci: comparison of API and BBL Crystal systems. J Med Microbiol 48, 695-696.

Hancock, L. E. and Gilmore, M. S. (2002) The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A 99, 1574-1579.

Handwerger, S. and Skoble, J. (1995) Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 39, 2446-2453.

Hayden, M. K., Trenholme, G. M., Schultz, J. E. and Sahm, D. F. (1993) In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis 167, 1224-1227.

Herwaldt, L. A. (1999) Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 106, 11S-18S; discussion 48S-52S.

Hodel-Christian, S. L. and Murray, B. E. (1991) Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother 35, 1147-1152.

Huebner, J., Wang, Y., Krueger, W. A. etal. (1999) Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun 67, 1213-1219.

Ike, Y. and Clewell, D. B. (1992) Evidence that the hemolysin/bacteriocin phenotype of Enterococcus faecalis subsp. zymogenes can be determined by plasmids in different incompatibility groups as well as by the chromosome. J Bacteriol 174, 8172-8177.

Ike, Y., Clewell, D. B., Segarra, R. A. and Gilmore, M. S. (1990) Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J Bacteriol 172, 155-163.

Jensen, L. B., Hammerum, A. M., Aerestrup, F. M. etal. (1998) Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob Agents Chemother 42, 3330-3331.

Kanematsu, E., Deguchi, T., Yasuda, M. etal. (1998) Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 42, 433-435.

Ke, D., Picard, F. J., Martineau, F. etal. (1999) Development of a PCR assay for rapid detection of enterococci. J Clin Microbiol 37, 3497-3503.

Knudtson, L. M. and Hartman, P. A. (1992) Routine procedures for isolation and identification of enterococci and fecal streptococci. Appl Environ Microbiol 58, 3027-3031.

Korten, V., Huang, W. M. and Murray, B. E. (1994) Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 38, 2091-2094.

Lautenbach, E., Schuster, M. G., Bilker, W. B. and Brennan, P. J. (1998) The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis 27, 1259-1265.

Law-Brown, J. and Meyers, P. R. (2003) Enterococcus phoeniculicola sp. nov., a novel member of the enterococci isolated from the uropygial gland of the Red-billed Woodhoopoe, Phoeniculus purpureus. Int J Syst Evol Microbiol 53, 683-685.

Leach, T. S., Schaser, R. J., Hempsall, K. A. etal. (2000) Clinical efficacy of linezolid for infections caused by vancomycin-resistant enterococci (VRE) in a compassionate-use program. Clin Infect Dis 31, 224 [abstract, 66].

Leclercq, R., Dutka-Malen, S., Brisson-Noel, A. etal. (1992) Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 15, 495-501.

Lefort, A., Baptista, M., Fantin, B. etal. (1999) Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother 43, 476-482.

Lefort, A., Mainardi, J. L., Tod, M. and Lortholary, O. (2000) Antienterococcal antibiotics. Med Clin North Am 84, 1471-1495.

Lewis, C. M. and Zervos, M. J. (1990) Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis 9, 111-117.

Ligozzi, M., Bernini, C., Bonora, M. G. etal. (2002) Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J Clin Microbiol 40, 1681-1686.

Low, Y. L., Jakubovics, N. S., Flatman, J. C. etal. (2003) Manganese-dependent regulation of the endocarditis-associated virulence factor EfaA of Enterococcus faecalis. J Med Microbiol 52, 113-119.

Luginbuhl, L. M., Rotbart, H. A., Facklam, R. R. etal. (1987) Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J 6, 1022-1026.

Maki, D. G. and Agger, W. A. (1988) Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 67, 248-269.

Malik, R. K., Montecalvo, M. A., Reale, M. R. etal. (1999) Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 18, 352-356.

Manero, A. and Blanch, A. R. (2002) Identification of Enterococcus spp. based on specific hybridisation with 16S rDNA probes. J Microbiol Methods 50, 115-121.

Marshall, S. H., Donskey, C. J., Hutton-Thomas, R. etal. (2002) Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 46, 3334-3336.

Martinez-Murcia, A. J. and Collins, M. D. (1991) Enterococcus sulfureus, a new yellow-pigmented Enterococcus species. FEMS Microbiol Lett 64, 69-74.

Mathai, D., Jones, R. N. and Pfaller, M. A., SENTRY Participant Group North America (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40, 129-136.

Megran, D. W. (1992) Enterococcal endocarditis. Clin Infect Dis 15, 63-71.

Moellering, R. C., Linden, P. K., Reinhardt, J. etal. (1999) The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. J Antimicrob Chemother 44, 251-261.

Montravers, P., Mohler, J., Saint Julien, L. and Carbon, C. (1997) Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 65, 144-149.

Morris, J. G. Jr, Shay, D. K., Hebden, J. N. etal. (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a University medical center. Ann Intern Med 123, 250-259.

Murray, B. E. (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3, 46-65.

Murray, B. E. (1992) Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 36, 2355-2359.

Murray, B. E. (1997) Vancomycin-resistant enterococci. Am J Med 102, 284-293.

Murray, B. E., Singh, K. V., Ross, R. P. etal. (1993) Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J Bacteriol 175, 5216-5223.

Nallapareddy, S. R., Qin, X., Weinstock, G. M. etal. (2000) Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect Immun 68, 5218-5224.

Navarro, F. and Courvalin, P. (1994) Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 38, 1788-1793.

NCCLS (2003) MIC Testing — Supplemental Tables. NCCLS Document M100-S13 (M7). Wayne, PA: National Committee for Clinical Laboratory Standards.

NNIS (2001) National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. Am J Infect Control 29, 404-421.

Noskin, G. A., Peterson, L. R. and Warren, J. R. (1995) Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 20, 296-301.

Olaison, L. and Schadewitz, K., Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis (2002) Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 34, 159-166.

Ozawa, Y., Courvalin, P. and Gaiimand, M. (2000) Identification of enterococci at the species level by sequencing of the genes for D-alanine:D-alanine ligases. Syst Appl Microbiol 23, 230-237.

Pallares, R., Pujol, M., Pena, C. etal. (1993) Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 153, 1581-1586.

Patterson, J. E. and Zervos, M. J. (1990) High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 12, 644-652.

Patterson, J. E., Sweeney, A. H., Simms, M. etal. (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74, 191-200.

Paulsen, I. T., Banerjei, L., Myers, G. S. etal. (2003) Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299, 2071-2074.

Poyart, C., Quesnes, G. and Trieu-Cuot, P. (2000) Sequencing the gene encoding manganese-dependent superoxide dismutase for rapid species identification of enterococci. J Clin Microbiol 38, 415-418.

Prystowsky, J., Siddiqui, F., Chosay, J. etal. (2001) Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45, 2154-2156.

Rakita, R. M., Quan, V. C., Jacques-Palaz, K. etal. (2000) Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium. FEMS Immunol Med Microbiol 28, 291-299.

Rasmussen, B. A., Gluzman, Y. and Tally, F. P. (1994) Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob Agents Chem-other 38, 1658-1660.

Rice, L. B. and Marshall, S. H. (1992) Evidence of incorporation of the chromosomal beta-lactamase gene of Enterococcus faecalis CH19 into a transposon derived from staphylococci. Antimicrob Agents Chemother 36, 1843-1846.

Rice, L. B., Calderwood, S. B., Eliopoulos, G. M. etal. (1991) Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Rev Infect Dis 13, 1-7.

Roberts, M. C. (1996) Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev 19, 1-24.

Roberts, M. C., Sutcliffe, J., Courvalin, P. etal. (1999) Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43, 2823-2830.

Sader, H. S., Biedenbach, D. and Jones, R. N. (1995) Evaluation of Vitek and API 20S for species identification of enterococci. Diagn Microbiol Infect Dis 22, 315-319.

Safdar, A., Bryan, C. S., Stinson, S. and Saunders, D. E. (2002) Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clin Infect Dis 34, E61-E63.

Sandoe, J. A., Witherden, I. R., Au-Yeung, H. K. etal. (2002) Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother 50, 577-582.

Schleifer, K. H. and Kilpper-Bálz, R. (1984) Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. Int J Syst Bacteriol 34, 31-34.

Shankar, N., Lockatell, C. V., Baghdayan, A. S. etal. (2001) Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 69, 4366-4372.

Sherman, J. M. (1937) The streptococci. Bacteriol Rev 1, 3-97.

Shinabarger, D. L., Marotti, K. R., Murray, R. W. etal. (1997) Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 41, 2132-2136.

Shlaes, D. M., Levy, J. and Wolinsky, E. (1981) Enterococcal bacteremia without endocarditis. Arch Intern Med 141, 578-581.

Singh, K. V., Coque, T. M., Weinstock, G. M. and Murray, B. E. (1998a) In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol Med Microbiol 21, 323-331.

Singh, K. V., Qin, X., Weinstock, G. M. and Murray, B. E. (1998b) Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J Infect Dis 178, 1416-1420.

Singh, K. V., Malathum, K. and Murray, B. E. (2001) Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother 45, 263-266.

Singh, K. V., Weinstock, G. M. and Murray, B. E. (2002) An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 46, 1845-1850.

Sohn, A. H., Garrett, D. O., Sinkowitz-Cochran, R. L. etal. (2001) Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 139, 821-827.

Soltani, M., Beighton, D., Philpott-Howard, J. and Woodford, N. (2000) Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob Agents Chemother 44, 433-436.

Suppola, J. P., Volin, L., Valtonen, V. V. and Vaara, M. (1996) Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 23, 694-697.

Suppola, J. P., Kuikka, A., Vaara, M. and Valtonen, V. V. (1998) Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia. Scand J Infect Dis 30, 153-157.

Svec, P., Devriese, L. A., Sedlacek, I. etal. (2001) Enterococcus haemoperoxidus sp. nov. and Enterococcus moraviensis sp. nov., isolated from water. Int J Syst Evol Microbiol 51, 1567-1574.

Swenson, J. M., Ferraro, M. J., Sahm, D. F. etal. (1992) New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci. J Clin Microbiol 30, 2525-2528.

Teixeira, L. M., Carvalho, M. G., Espinola, M. M. etal. (2001) Enterococcus porcinus sp. nov. and Enterococcus ratti sp. nov., associated with enteric disorders in animals. Int J Syst Evol Microbiol 51, 1737-1743.

Teng, F., Jacques-Palaz, K. D., Weinstock, G. M. and Murray, B. E. (2002) Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to phago-cytic killing of E. faecalis. Infect Immun 70, 2010-2015.

Toledo-Arana, A., Valle, J., Solano, C. etal. (2001) The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 67, 4538-4545.

Tyrrell, G. J., Bethune, R. N., Willey, B. and Low, D. E. (1997) Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol 35, 1054-1060.

Tyrrell, G. J., Turnbull, L., Teixeira, L. M. etal. (2002) Enterococcus gilvus sp. nov. and Enterococcus pallens sp. nov. isolated from human clinical specimens. J Clin Microbiol 40, 1140-1145.

Vancanneyt, M., Snauwaert, C., Cleenwerck, I. etal. (2001) Enterococcus villorum sp. nov., an enteroadherent bacterium associated with diarrhoea in piglets. Int J Syst Evol Microbiol 51, 393-400.

Vincent, S., Knight, R. G., Green, M. et al. (1991) Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol 29, 2335-2337.

Weinstein, M. R., Dedier, H., Brunton, J. etal. (1999) Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 29, 361-366.

Wells, L. D. and von Graevenitz, A. (1980) Clinical significance of enterococci in blood cultures from adult patients. Infection 8, 147-151.

Willey, B. M., Jones, R. N., McGeer, A. etal. (1999) Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis 34, 165-171.

Williams, A. M., Rodrigues, U. M. and Collins, M. D. (1991) Intrageneric relationships of Enterococci as determined by reverse transcriptase sequencing of small-subunit rRNA. Res Microbiol 142, 67-74.

Winston, D. J., Emmanouilides, C., Kroeber, A. etal. (2000) Quinupristin/ dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 30, 790-797.

Wong, M. T., Kauffman, C. A., Standiford, H. C. etal. (2001) Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 33, 1476-1482.

0 0

Post a comment